We are live on ! Find out more
FEED

ENvue Medical Inc

13 hedge funds and large institutions have $179K invested in ENvue Medical Inc in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more capital invested

Capital invested by funds: $42.5K → $179K (+$137K)

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

117% more funds holding

Funds holding: 613 (+7)

5.61% more ownership

Funds ownership: 1.69%7.3% (+5.6%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
13
Holders Change
+7
Holders Change %
+116.67%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q1 2026 in Review

13 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2026, worth a combined $179K — up 322% from $42.5K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FEED positions and 3 closed out — a net gain of 7 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $48.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38.2K sold.

  • 13 institutional investors held ENvue Medical Inc (FEED) as of Q1 2026, up from 6 in Q4 2025.
  • Funds reported $179K of ENvue Medical Inc stock for Q1 2026, up 322% quarter-over-quarter.
  • 10 funds opened new ENvue Medical Inc positions in Q1 2026 and 3 closed out, a net change of +7 holders.
  • The largest ENvue Medical Inc buyer in Q1 2026 was Geode Capital Management, an estimated $48.5K added.
  • The largest ENvue Medical Inc seller in Q1 2026 was Citadel Advisors, an estimated $38.2K sold.

Based on aggregated 13F filings for Q1 2026.